FinTrust Capital Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$59.5K Buy
358
+1
+0.3% +$151 0.01% 532
2024
Q2
$47.5K Sell
357
-110
-24% -$13.2K 0.01% 551
2024
Q1
$49.1K Sell
467
-430
-48% -$38.6K 0.01% 525
2023
Q4
$67.8K Buy
897
+467
+109% +$29.6K 0.01% 427
2023
Q3
$28.3K Hold
430
0.01% 587
2023
Q2
$21K Hold
430
0.01% 644
2023
Q1
$21K Hold
430
0.01% 641
2022
Q4
$21K Buy
+430
New +$19.9K 0.01% 639

Other funds holding THC

FinTrust Capital Advisors's THC Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Tenet Healthcare (THC) stake by 0.28% in Q3 2024, buying an estimated $151 and bringing the position to 358 shares worth $59.5K. The position accounts for 0.01% of the portfolio, ranked #532.

FinTrust Capital Advisors first reported a position in THC in Q4 2022 and has held it in 8 quarters since. The position peaked at $67.8K in Q4 2023. 602 funds tracked by Wall St. Rank hold THC as of Q3 2024.

  • FinTrust Capital Advisors held 358 shares of Tenet Healthcare worth $59.5K as of Q3 2024.
  • FinTrust Capital Advisors bought 1 Tenet Healthcare share in Q3 2024, an estimated $151.
  • Tenet Healthcare made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #532 holding.
  • FinTrust Capital Advisors first reported a position in Tenet Healthcare in Q4 2022 and has held it in 8 quarters since.
  • FinTrust Capital Advisors's Tenet Healthcare position peaked at $67.8K in Q4 2023.
  • 602 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.